Gastro-resistant controlled release oral dosage forms Grant US-11464744-B2 United States of America 11 Oct 2022
Use of roluperidone to treat negative symptoms and disorders, increase neuroplasticity… Grant US-11083723-B2 United States of America 10 Aug 2021
Compositions and methods for treating schizophrenia Grant US-10799493-B2 United States of America 13 Oct 2020